Who owns Ascendis Pharma?

Ascendis Pharma is formerly owned by Sofinnova Partners, through Sofinnova Capital VII, since 2012.

When did Sofinnova Partners acquire Ascendis Pharma?

Sofinnova Partners acquired Ascendis Pharma in 2012 and exited after 3 years.

Has Ascendis Pharma been sold?

Yes. Ascendis Pharma was exited in 2015 via IPO.

Home/Companies/Biotech/Ascendis Pharma

Ascendis Pharma

Biotech·

Denmark·Exited 2015·Held 3yr

Ascendis Pharma is a healthcare / biotech company, headquartered in Denmark.

Entry

2012

Hold

3yr

Exit

2015

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQDenmark

SectorHealthcare / Biotech

Danish specialty pharma company using its TransCon prodrug technology in endocrinology and CNS, which went public on Nasdaq in 2015. IPO…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from Sofinnova Capital VII

Other portfolio companies in the same fund.

Advanced Perfusion Diagnostics

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings